What Are Peptides?

A peptide is a short chain of amino acids linked by amide bonds — called peptide bonds — each formed when the carboxyl group of one amino acid reacts with the amino group of the next, releasing a molecule of water. The specific order of amino acids in that chain is the peptide's primary structure, and it's what a sequence notation (for example Gly-Pro-Glu) describes.

Chain length is what separates the informal categories chemists use: a dipeptide is two amino acids, an oligopeptide is roughly two to twenty, and a polypeptide is a longer chain still. There's no single official cutoff where "peptide" stops and "protein" starts — see the next section — but research peptides typically fall in a molecular-weight range of a few hundred to a few thousand daltons.

The distinction is a continuum, not a bright line. Peptides are generally short chains — on the order of two to fifty amino acids — that behave as flexible, extended molecules rather than folding into one stable three-dimensional shape. Proteins are longer chains that typically do fold into defined structures (alpha helices, beta sheets, and larger assemblies of those elements), which is why proteins are usually described by their folded structure and proteins are usually studied by both sequence and structure, while peptides are described chiefly by sequence and molecular weight.

Some peptides occur naturally as signaling molecules that carry information between cells; others are designed sequences with no natural counterpart at all. Either way, the chemistry — amino acids joined by peptide bonds — is the same.

Solid-Phase Peptide Synthesis (SPPS)

Nearly every peptide sold for laboratory research today is made by solid-phase peptide synthesis, a method developed by Robert Bruce Merrifield in the 1960s (Nobel Prize in Chemistry, 1984). The chain is built one amino acid at a time on an insoluble polymer resin bead, which acts as a handle that keeps the growing chain anchored while it's washed clean between steps.

Each cycle has two parts. Deprotection removes a temporary protecting group from the resin-bound chain's exposed amino group. Coupling then attaches the next protected amino acid, activated so it can form a new peptide bond. The two most common protecting-group chemistries are Fmoc (fluorenylmethyloxycarbonyl, removed with a mild base) and Boc (tert-butyloxycarbonyl, removed with acid); Fmoc chemistry is more common in a modern synthesis lab because its conditions are milder.

After the final amino acid is added, the finished chain is cleaved from the resin and any remaining side-chain protecting groups are removed, typically with a strong acid such as trifluoroacetic acid. What comes off the resin at that point is crude peptide: a mixture of the target sequence plus side products — deletion sequences, truncated chains, and similar byproducts of a multi-step synthesis — that has to be purified before it's usable as a reference material.

Crude peptide is purified by preparative high-performance liquid chromatography (HPLC), which separates molecules as they're pushed through a column under pressure, based on how strongly each one interacts with the column packing. The purified fractions are then re-run on analytical HPLC under conditions where the target sequence and any remaining impurities produce separate peaks; the area under the target peak, as a percentage of the total peak area, is the "purity by HPLC" figure on a certificate of analysis (COA).

A COA that shows only an HPLC trace confirms purity, not identity — it takes mass spectrometry, which confirms the molecule's mass matches its expected molecular weight, to also confirm that the dominant peak really is the intended sequence and not a different molecule that happens to elute at the same time. Reputable suppliers publish both.

A related but separate figure is net peptide content: how much of the vial's mass is the peptide itself, as opposed to non-peptide mass such as counter-ions, salts, or residual water. It's determined by amino acid analysis rather than HPLC, and it can vary from lot to lot even when HPLC purity stays constant.

Purified peptide is normally freeze-dried — lyophilized — before it ships. The purified solution is frozen, then dried under vacuum so the water sublimates directly from a solid to a gas without passing through a liquid phase. Lyophilization is used because a peptide in solution is chemically far less stable than the same peptide as a dry solid; freeze-drying is what lets a peptide be shipped and stored at room temperature for an extended period rather than needing a cold chain from the synthesis lab to the bench.

The result is a stable, dry solid — sometimes a compact cake, sometimes a loose powder, depending on vial geometry and the freeze-drying cycle used, not any difference in what's inside the vial. It has to be reconstituted with an appropriate diluent before it can be used in solution-based lab work; see the companion guide, How to Reconstitute Peptides, for that procedure.

"Research use only" isn't marketing language; it's the basis on which a chemical supplier is permitted to sell these compounds at all. Reference peptides are not manufactured, tested, or labeled as drugs — there is no clinical testing, no finished-drug stability program, and no regulatory drug approval behind them, because they are not intended to become a drug product. They exist to be characterized, compared, and handled on a bench by people trained to work with laboratory chemicals, inside a laboratory.

That framing is why the products themselves carry no dosing instructions, why supplier listings avoid medical claims, and why documentation is analytical (certificates of analysis, HPLC/MS traces) rather than a patient information leaflet. Every Quill Peptides product is sold on that same basis.

• How to Reconstitute Peptides
• Research Library
• Shop Research Peptides